AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 20 filers reported holding AMBRX BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,560 | +84.5% | 702,291 | 0.0% | 0.36% | -3.8% |
| Q1 2023 | $6,264 | +28.2% | 702,291 | -67.4% | 0.37% | +36.3% |
| Q4 2022 | $4,886 | -99.8% | 2,152,291 | 0.0% | 0.27% | +175.8% |
| Q3 2022 | $2,324,000 | -59.3% | 2,152,291 | 0.0% | 0.10% | -67.5% |
| Q2 2022 | $5,704,000 | -35.7% | 2,152,291 | 0.0% | 0.30% | -17.8% |
| Q1 2022 | $8,867,000 | -54.4% | 2,152,291 | 0.0% | 0.37% | -29.6% |
| Q4 2021 | $19,435,000 | +69.4% | 2,152,291 | +153.2% | 0.53% | +105.1% |
| Q3 2021 | $11,475,000 | -31.1% | 850,000 | 0.0% | 0.26% | -24.0% |
| Q2 2021 | $16,660,000 | – | 850,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,932,591 | $5,121,000 | 0.71% |
| Cormorant Asset Management, LP | 2,486,386 | $6,589,000 | 0.50% |
| Artal Group S.A. | 2,152,291 | $5,704,000 | 0.30% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,491,832 | $3,953,000 | 0.15% |
| Octagon Capital Advisors LP | 122,800 | $325,000 | 0.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,027,291 | $5,372,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 19,063 | $51,000 | 0.00% |
| FMR LLC | 3,857,679 | $10,223,000 | 0.00% |
| Renaissance Technologies | 11,000 | $29,000 | 0.00% |
| UBS Group AG | 242 | $1,000 | 0.00% |